ClassID:

92055

C07C65/26 - CPC Classification

Classification description:

Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic containing rings other than six-membered aromatic rings

Recent Application in this class:
#1
20260000631
2026-01-01

SYNTHETIC RETINOIDS FOR USE IN RAR ACTIVATION

#2
20250346549
2025-11-13

NOVEL AROMATIC MOLECULES

#3
20250084023
2025-03-13

NOVEL AROMATIC MOLECULES

#4
20240189268
2024-06-13

SESQUITERPENE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND USE THEREOF

#5
20240140895
2024-05-02

NOVEL AROMATIC MOLECULES

#6
20240036466
2024-02-01

Onium Salt, Resist Composition, And Patterning Process

#7
20220144783
2022-05-12

SYNTHETIC RETINOIDS FOR USE IN RAR ACTIVATION

#8
20220123220
2022-04-21

COMPOUND AND LIGHT EMITTING ELEMENT USING SAME

#9
20170152206
2017-06-01

IRE-1α inhibitors

#10
20160060205
2016-03-03

Method of preparing fused ring indeno compounds

#11
20150148347
2015-05-28

Indanyloxyphenylcyclopropanecarboxylic acids

#12
20150141696
2015-05-21

PROCESS FOR THE PREPARATION OF ADAPALENE AND RELATED COMPOUNDS

#13
20150141662
2015-05-21

Method of preparing fused ring indeno compounds

#14
20150094330
2015-04-02

Compounds and methods for skin repair

#15
20140213552
2014-07-31

Cyclohexylamines

#16
20130101667
2013-04-25

Cyclohexylamines

#17
20130072553
2013-03-21

DRUGS, DERIVATIVES AND ANALOGS CONTAINING ADAMANTANE STRUCTURES OF NEW INDICATION APPLICATIONS OF ANTI-TUMOR

#18
20130030214
2013-01-31

Process for the preparation of adapalene and related compounds

#19
20120077970
2012-03-29

Method for preparing molecular complexes between adapalene and cyclodextrins

#20
20120016031
2012-01-19

Biphenyl compound selective agonists of gamma RAR receptors

#21
20110065162
2011-03-17

IRE-1α inhibitors

#22
20110046237
2011-02-24

Compounds with activity at estrogen receptors

#23
20110040115
2011-02-17

INTERMEDIATES AND PROCESS FOR THE PREPARATION OF AROMATIC DERIVATIVES OF 1-ADAMANTANE

#24
20100298276
2010-11-25

Thyroid receptor ligands

#25
20100234456
2010-09-16

Biaryl carboxylic acid apoptosis promoters

#26
20100160677
2010-06-24

PROCESS FOR PREPARATION OF 6-[3-(1-ADMANTYL)-4-METHOXYPHENYL]-2-NAPHTOIC ACID.

#27
20100076219
2010-03-25

Method for preparation of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphtoic acid

#28
20100074861
2010-03-25

Compounds having a cyclic moiety and compositions for delivering active agents

#29
20100010265
2010-01-14

PROCESS FOR THE PREPARATION OF AROMATIC DERIVATIVES OF 1-ADAMANTANE

#30
20090186893
2009-07-23

IRE-1α inhibitors

#31
20090137841
2009-05-28

Process for the preparation of aromatic derivatives of 1-adamantane

#32
20090131713
2009-05-21

Process for the preparation of adapalene and related compounds

#33
20090023811
2009-01-22

Biphenyl compound selective agonists of gamma RAR receptors

#34
20080108848
2008-05-08

Process for the preparation of synthetic retinoids with disubstituted adamantyl radical

#35
20080027244
2008-01-31

Method for Manufacturing Aromatic Dicarboxylic Acid

#36
20070259836
2007-11-08

Therapeutic cyclopentane derivatives

#37
20070225288
2007-09-27

Indene derivatives and process for the preparation thereof

#38
20070135392
2007-06-14

Apoptosis promoters

#39
20060229465
2006-10-12

Process for the preparation of adapalene

#40
20060122278
2006-06-08

Compounds with activity at estrogen receptors

#41
20060116427
2006-06-01

Adapalene polymorphic forms

#42
20050256210
2005-11-17

Compounds with activity at estrogen receptors

#43
20050203269
2005-09-15

Dicarboxylic acids for dielectrics having barrier effect against copper diffusion

#44
20050148670
2005-07-07

Ligand inhibitors of the RAR receptors, process for preparing same and therapeutic/cosmetic applications thereof

#45
20050131033
2005-06-16

Ligand inhibitors of the RAR receptors, process for preparing same and therapeutic/cosmetic applications thereof

#46
20050107347
2005-05-19

Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders

#47
20050004184
2005-01-06

Thyroid receptor ligands